SG Americas Securities’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Buy	14,382 +864	+6%	+$60.4K	﹤0.01%	1755
2025 Q4	$1.11M	Buy	13,518 +7,339	+119%	+$548K	﹤0.01%	1931
2025 Q3	$367K	Sell	6,179 -27,833	-82%	-$1.37M	﹤0.01%	2352
2025 Q2	$1.38M	Buy	34,012 +28,789	+551%	+$1.3M	0.01%	963
2025 Q1	$268K	Buy	5,223 +2,062	+65%	+$102K	﹤0.01%	2305
2024 Q4	$175K	Sell	3,161 -4,081	-56%	-$185K	﹤0.01%	2275
2024 Q3	$238K	Buy	7,242 +3,379	+87%	+$95K	﹤0.01%	2350
2024 Q2	$105K	Sell	3,863 -6,811	-64%	-$229K	﹤0.01%	2525
2024 Q1	$388K	Sell	10,674 -44,305	-81%	-$1.3M	﹤0.01%	1547
2023 Q4	$1.11M	Buy	54,979 +4,266	+8%	+$71.2K	0.01%	967
2023 Q3	$901K	Buy	50,713 +9,141	+22%	+$162K	0.01%	1355
2023 Q2	$751K	Buy	+41,572	New	+$661K	0.01%	1206
2022 Q3	–	Sell	-50,512	Closed	-$737K	–	3550
2022 Q2	$737K	Buy	50,512 +8,073	+19%	+$121K	0.01%	1596
2022 Q1	$714K	Sell	42,439 -1,891	-4%	-$35.1K	0.01%	1653
2021 Q4	$997K	Sell	44,330 -1,923	-4%	-$50K	0.01%	1649
2021 Q3	$997K	Buy	46,253 +23,276	+101%	+$576K	﹤0.01%	1909
2021 Q2	$666K	Buy	+22,977	New	+$718K	﹤0.01%	1801